Clincosm LogoSign in Get a demo

Diffuse Large B-Cell Lymphoma (DLBCL)

Showing 26 - 31 of 31
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphomas Non-Hodgkin's B-Cell, Diffuse Large B-cell Lymphoma (DLBCL), Primary Mediastinal B-cell Lymphoma (PMBCL) Trial in

Recruiting
  • Lymphomas Non-Hodgkin's B-Cell
  • +5 more
  • WZTL002-1 (1928T2z CAR-T cells)
  • Cyclophosphamide and Fludarabine lymphodepleting chemotherapy
  • Wellington, New Zealand
    Wellington Hospital, Capital & Coast District Health Board
Feb 18, 2020

Lymphoma, B-cell, Lymphoma, Non-Hodgkin, Diffuse Large B-cell Lymphoma (DLBCL) Trial in Stanford (Autologous hematopoietic stem

Terminated
Has Results
  • Lymphoma, B-cell
  • +3 more
  • Autologous hematopoietic stem cell transplantation (auto-HSCT)
  • +14 more
  • Stanford, California
    Stanford University School of Medicine
May 11, 2018

Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma Grade III (FL III°), Mantle Cell Lymphoma (MCL), Blastoid Variant

Terminated
  • Diffuse Large B-cell Lymphoma (DLBCL)
  • +4 more
  • Bremen, Germany
  • +11 more
Jan 17, 2018

DLBCL (DLBCL), Follicular NHL Grade 3b Trial in Worldwide (Rituximab)

Completed
  • Diffuse Large B-Cell Lymphoma (DLBCL)
  • Follicular NHL Grade 3b
  • Wodonga, Victoria, Australia
  • +130 more
May 25, 2016

Diffuse Large B-cell Lymphoma (DLBCL) Trial in Seoul (Rituximab)

Completed
  • Diffuse Large B-cell Lymphoma (DLBCL)
  • Seoul, Korea, Republic of
    Samsung Medical Center
Sep 26, 2012

DLBCL (DLBCL) Trial in Alcala de Henares (Dexamethasone and dose-dense immunochemoterapy)

Unknown status
  • Diffuse Large B-Cell Lymphoma (DLBCL)
  • Dexamethasone and dose-dense immunochemoterapy
  • Alcala de Henares, Madrid, Spain
    Principe de Asturias University Hospital
Feb 11, 2010